利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

6 条记录 (耗时 0.011 秒)

    ABLATION SYSTEM
    2.
    发明授权
    ABLATION SYSTEM 有权
    消融系统

    公开(公告)号：EP1401346B1

    公开(公告)日：2010-10-27

    申请号：EP02721819.7

    申请日：2002-04-25

    申请人： Medtronic, Inc.

    发明人： FRANSISCHELLI, David, E. ,  SKARDA, James, R. ,  STEWART, Mark, T. ,  MEHR, Rahul

    IPC分类号： A61B18/00

    CPC分类号： A61B18/1206 ,  A61B18/1445 ,  A61B2018/0016 ,  A61B2018/00351 ,  A61B2018/00363 ,  A61B2018/00577 ,  A61B2018/00702 ,  A61B2018/00761 ,  A61B2018/00791 ,  A61B2018/00875 ,  A61B2018/00886 ,  A61B2018/1467 ,  A61B2218/002

    摘要： A system and method for creating lesions and assessing their completeness or transmurality. Assessment of transmurality of a lesion is accomplished by monitoring the impedance of the tissue to be ablated. Rather than attempting to detect a desired drop or a desired increase impedance, completeness of a lesion is detected in response to the measured impedance remaining at a stable level for a desired period of time, referred to as an impedance plateau. The mechanism for determining transmurality of lesions adjacent individual electrodes or pairs may be used to deactivate individual electrodes or electrode pairs, when the lesions in tissue adjacent these individual electrodes or electrode pairs are complete, to create an essentially uniform lesion along the line of electrodes or electrode pairs, regardless of differences in tissue thickness adjacent the individual electrodes or electrode pairs.

    摘要翻译： 用于创建病变并评估其完整性或透壁性的系统和方法。 通过监测待消融的组织的阻抗来完成对损伤的透壁性的评估。 响应于所测量的阻抗保持在稳定水平持续期望的时间段（被称为阻抗平台），而不是试图检测期望的下降或期望的增加阻抗，而是检测损伤的完整性。 当邻近单个电极或电极对的组织中的损伤完成时，用于确定邻近单独电极或对的损伤的透壁性的机制可用于使个别电极或电极对失活，以沿电极线创建基本上均匀的损伤，或者 而不管邻近单个电极或电极对的组织厚度的差异。

    A METHOD AND SYSTEM FOR TREATING AN ATRIAL ARRHYTHMIA
    3.
    发明公开
    A METHOD AND SYSTEM FOR TREATING AN ATRIAL ARRHYTHMIA 有权
    一种治疗心房心律失常的方法和系统

    公开(公告)号：EP1469898A1

    公开(公告)日：2004-10-27

    申请号：EP03707537.1

    申请日：2003-01-27

    申请人： Medtronic,Inc.

    发明人： MEHR, Rahul ,  KLEIN, George, J. ,  UJHELYI, Michael, R.

    IPC分类号： A61M5/142 ,  G06F17/00 ,  A61N1/05

    CPC分类号： A61M5/14244 ,  A61B2017/00044 ,  A61M5/1723 ,  A61M2230/04 ,  A61N1/3621

    摘要： A method and system is provided for responding, from internally within a patient, to an atrial arrhythmia in a heart including measuring from within the patient at least one electrocardiogram characteristic indicative of the atrial arrhythmia, and controlling from within the patient drug therapy delivery to the patient responsive to measuring the at least one electrocardiogram characteristic. Drug therapy is initiated to the patient responsive to measuring the at least one electrocardiogram characteristic. According to one aspect of the present invention, the drug therapy is staged within the patient prior to measuring the at least one electrocardiogram characteristic. According to another example embodiment, the heart is paced from within the patient at a predefined rate responsive to measuring the at least one electrocardiogram characteristic, pacing occurring alone, or in combination with drug therapy.

    摘要翻译： 提供了一种方法和系统，用于从患者体内内部响应心脏中的心房心律不齐，包括从患者体内测量至少一个指示房性心律失常的心电图特征，并且从患者体内控制药物治疗递送至 患者响应于测量至少一个心电图特征。 响应于测量至少一个心电图特征而对患者开始药物治疗。 根据本发明的一个方面，在测量至少一个心电图特征之前，药物治疗在患者体内分阶段进行。 根据另一个示例实施例，响应于测量至少一个心电图特征，单独起搏或与药物治疗组合，以预定速率从患者体内起搏心脏。